biotech · Attention-Deficit Hyperactivity Disorder (ADHD) · ABVC
ABVC BIOPHARMA
ABVC BIOPHARMA, INC.
ABVC BIOPHARMA patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Fremont, USA HQ
2015 Founded
10 Employees
Public company Type
ABVC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Fremont, USA
- Founded
- 2015
- Employees
- 10
- Programs
- 1
- Drugs
- 1
- Patents
- 0
ABVC BIOPHARMA patents
0 pharmaceutical patents indexed for ABVC BIOPHARMA. 0 expire within 24 months.
ABVC BIOPHARMA has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does ABVC BIOPHARMA have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do ABVC BIOPHARMA patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.